Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.

Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA; Mupirocin And The Risk Of Staphylococcus Aureus Study Team.

N Engl J Med. 2002 Jun 13;346(24):1871-7.

2.

Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.

Wertheim HF, Vos MC, Ott A, Voss A, Kluytmans JA, Vandenbroucke-Grauls CM, Meester MH, van Keulen PH, Verbrugh HA.

Ann Intern Med. 2004 Mar 16;140(6):419-25.

PMID:
15023707
3.
4.

Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery.

Konvalinka A, Errett L, Fong IW.

J Hosp Infect. 2006 Oct;64(2):162-8. Epub 2006 Aug 23.

PMID:
16930768
6.

Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.

Doebbeling BN, Reagan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP.

Arch Intern Med. 1994 Jul 11;154(13):1505-8.

PMID:
8018006
7.

Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls.

Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, Spies-van Rooijen NH.

Acta Orthop Scand. 1998 Aug;69(4):412-4.

PMID:
9798453
8.

Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study.

Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GA, Stuurman A, van Belkum A, Kluytmans JA.

Clin Infect Dis. 2002 Aug 15;35(4):353-8. Epub 2002 Jul 15.

9.

Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.

van Rijen M, Bonten M, Wenzel R, Kluytmans J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006216. doi: 10.1002/14651858.CD006216.pub2. Review.

PMID:
18843708
10.

Mupirocin to prevent S. aureus infections.

Farr BM.

N Engl J Med. 2002 Jun 13;346(24):1905-6. No abstract available.

PMID:
12063377
11.

Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review.

van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA.

J Antimicrob Chemother. 2008 Feb;61(2):254-61. doi: 10.1093/jac/dkm480. Epub 2008 Jan 3. Review.

12.

Intranasal mupirocin to prevent postoperative infections.

von Eiff C, Kipp F, Becker K.

N Engl J Med. 2002 Oct 10;347(15):1207-8; author reply 1207-8. No abstract available.

13.

[Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].

García AM, Villa MV, Escudero ME, Gómez P, Vélez MM, Múnera MI, Franco G.

Biomedica. 2003 Jun;23(2):173-9. Spanish.

PMID:
12872556
14.

The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients.

Boelaert JR, De Smedt RA, De Baere YA, Godard CA, Matthys EG, Schurgers ML, Daneels RF, Gordts BZ, Van Landuyt HW.

Nephrol Dial Transplant. 1989;4(4):278-81.

PMID:
2502734
16.
17.

Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment.

Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, Wenzel RP.

Ann Intern Med. 1991 Jan 15;114(2):101-6.

PMID:
1898585
18.
19.

Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.

Wertheim HF, Verveer J, Boelens HA, van Belkum A, Verbrugh HA, Vos MC.

Antimicrob Agents Chemother. 2005 Apr;49(4):1465-7.

20.

Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.

Trautmann M, Stecher J, Hemmer W, Luz K, Panknin HT.

Chemotherapy. 2008;54(1):9-16. Epub 2007 Dec 7. Review.

PMID:
18063862
Items per page

Supplemental Content

Write to the Help Desk